Search details
1.
Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
Clin Infect Dis
; 2024 Mar 11.
Article
in English
| MEDLINE | ID: mdl-38462673
2.
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
N Engl J Med
; 384(18): 1705-1718, 2021 05 06.
Article
in English
| MEDLINE | ID: mdl-33951360
3.
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
Am J Respir Crit Care Med
; 207(10): 1376-1382, 2023 05 15.
Article
in English
| MEDLINE | ID: mdl-36790881
4.
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Clin Infect Dis
; 75(4): 560-566, 2022 09 10.
Article
in English
| MEDLINE | ID: mdl-34918028
5.
Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship.
Clin Infect Dis
; 72(10): e448-e457, 2021 05 18.
Article
in English
| MEDLINE | ID: mdl-32785683
6.
Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
J Infect Dis
; 221(12): 2072-2082, 2020 06 11.
Article
in English
| MEDLINE | ID: mdl-32002554
7.
Four-Month Rifapentine Regimens for Tuberculosis. Reply.
N Engl J Med
; 386(11): 1095-1096, 2022 03 17.
Article
in English
| MEDLINE | ID: mdl-35294823
8.
Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020.
MMWR Morb Mortal Wkly Rep
; 69(12): 347-352, 2020 03 27.
Article
in English
| MEDLINE | ID: mdl-32214086
9.
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
BMC Infect Dis
; 20(1): 543, 2020 Jul 25.
Article
in English
| MEDLINE | ID: mdl-32711457
10.
Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014.
Emerg Infect Dis
; 22(3): 491-502, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26889786
11.
Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
Emerg Infect Dis
; 21(11): 2048-51, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26488585
12.
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
Emerg Infect Dis
; 21(6): 977-83, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25988299
13.
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
PLoS Med
; 12(12): e1001932, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26714320
14.
Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.
Clin Infect Dis
; 59(4): 465-72, 2014 Aug 15.
Article
in English
| MEDLINE | ID: mdl-24846639
15.
Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.
Clin Infect Dis
; 57(8): 1081-93, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23840002
16.
Acquired resistance to second-line drugs among persons with tuberculosis in the United States.
Clin Infect Dis
; 55(12): 1600-7, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22942206
17.
Site of extrapulmonary tuberculosis is associated with HIV infection.
Clin Infect Dis
; 55(1): 75-81, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22423123
18.
Challenges and controversies in defining totally drug-resistant tuberculosis.
Emerg Infect Dis
; 18(11): e2, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-23092736
19.
Optimizing drug inventory management with a web-based information system: The TBTC Study 31/ACTG A5349 experience.
Contemp Clin Trials
; 105: 106377, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33794353
20.
Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis.
Contemp Clin Trials
; 104: 106355, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33713841